Welcome to ImmunAID

ImmunAID is a large scale translational research project whose objective is to optimize the diagnostic, classification and clinical management of patients with auto–inflammatory disorders (AID). Indeed, there is a dramatic unmet need in several rare disorders characterized by huge clinical and biological inflammation, for which no robust and validated classification criteria have been established. The project focuses on rare sporadic AID of unknown pathogenesis and will enable the constitution of homogeneous groups of patients, through European existing cohorts of patients

Total Cost

15.8 M€

Partnership

24

EU contribution

15.8 M€

Partner countries

12

ImmunAID

Grant agreement no: 779295

Funded under: H2020-EU.3.1.1.

ue 80x53

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779295

Contact Info

INSERM
Institut National de la Santé et de la Recherche Médicale

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.